The Future of HER2+ Breast Cancer Treatment

October 20, 2016
Chau Dang, MD

Chau Dang, MD, medical oncologist, chief, West Harrison Medical Oncology Service, Memorial Sloan Kettering Cancer Center, discusses the future of HER2+ breast cancer treatment.